The chart below shows how KNW performed 10 days before and after its earnings report, based on data from the past quarters. Typically, KNW sees a -13.12% change in stock price 10 days leading up to the earnings, and a -16.35% change 10 days following the report. On the earnings day itself, the stock moves by -1.86%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Technology Licensing Expansion: NOLabs has launched the KTL program to expand its technology licensing, aiming to drive revenue from non-core fields of use of its platform technology.
Revolutionary Sensor Technology: The RFDS technology is a groundbreaking sensor platform that provides precise and non-invasive measurements, with applications in medical diagnostics and industrial processes.
Innovation Partnership Initiative: The KTL program aims to foster innovation by partnering with industry leaders and researchers, enhancing market presence and establishing RFDS as a standard technology.
RFDS Technology Advancement: NOLabs is committed to ongoing research and development to enhance RFDS capabilities, ensuring the technology remains state-of-the-art.
Cash Earnings Improvement: The company reported an 8% improvement in cash earnings year-over-year, indicating better operational efficiency despite a net loss.
R&D Expense Reduction: Research and development expenses decreased by 46% year-over-year, reflecting cost-saving measures and efficient use of resources.
Cash Burn Rate Reduction: The cash burn rate was reduced by 44% compared to the previous year, demonstrating improved financial management and operational adjustments.
Negative
Net Loss Increase: NOLabs reported a net loss of $4,670,000 for Q1 fiscal year 2025, an increase from a net loss of $3,450,000 in Q1 fiscal year 2024, indicating worsening financial performance.
Non-Cash Expense Impact: The company experienced a significant non-cash expense of $2,450,000, which accounted for 52% of the total net loss, primarily due to GAAP-based derivative accounting, reflecting increased volatility in reported earnings.
Declining Shareholder Equity: Shareholder equity was reported as negative $3,910,000, worsening from negative $3,160,000 in the previous fiscal year, indicating deteriorating financial health.
Liquidity Concerns: Despite a decrease in cash burn rate to $1,890,000, the company only had $1,030,000 in cash and cash equivalents, raising concerns about liquidity and operational sustainability until April 2025.
Stock Delisting Impact: The New York Stock Exchange has suspended trading of NOLabs stock and initiated a delisting process, which could negatively impact investor confidence and market perception.
Short Seller Impact: The company has been under attack by short sellers, which has complicated capital raising efforts and contributed to the stock's volatility.
Earnings call transcript: Know Labs Q1 2025 widens net loss, plans expansion
KNW.A
0%